Investor insights
Sectors invested in
Funding rounds participated in
$26M sweet spot round size
Most of their 12 investments are in rounds between $19M and $38M
Investor type
Basic info
Industry
Sectors
Date founded
2008
Investments made
辉大（上海）生物科技有限公司 raised undisclosed on May 12, 2022
Investors: 夏尔巴股权投资管理有限公司, CD Capital and Kunlun Capital Pte. Ltd.
CellOrigin Biotech raised $16M on March 29, 2022
Investors: Efung Capital, Jifeng Ventures 济峰资本 and Kunlun Capital Pte. Ltd.
Undisclosed raised $31M on March 14, 2022
Investors: 泰福资本 TF Capital, 江苏瑞华投资控股集团有限公司, Fosun Pharma, CDH Investments, 夏尔巴股权投资管理有限公司 and Kunlun Capital Pte. Ltd.
Nutshell Therapeutics raised $40M on March 14, 2022
Investors: 经纬创投（北京）投资管理顾问有限公司, Genesis Capital, LLC, Northern Light Venture Capital, Tencent and Kunlun Capital Pte. Ltd.
Undisclosed raised undisclosed on December 21, 2021
Investors: 灵均投资, Halo Capital, Maison Capital and Kunlun Capital Pte. Ltd.
上海环码生物医药有限公司 raised $20M on December 16, 2021
Investors: 凯泰资本, Cowin Venture Capital and Kunlun Capital Pte. Ltd.
Undisclosed raised $20M on December 16, 2021
Investors: 凯泰资本, K2VC 险峰, Efung Capital and Kunlun Capital Pte. Ltd.
Undisclosed raised $19M on October 14, 2021
Investors: 北京德联运通投资管理有限公司 and Kunlun Capital Pte. Ltd.
Undisclosed raised undisclosed on August 1, 2021
Investors: Kunlun Capital Pte. Ltd.
EdiGene Inc. raised $62M on April 21, 2021
Investors: 夏尔巴股权投资管理有限公司, 雅惠投资, Sequoia Capital China, Lilly Asia Ventures, IDG Capital Partners, Loyal Valley Capital, 华盖资本有限责任公司, 博远资本 and Kunlun Capital Pte. Ltd.